Hair Care Giant Olaplex Battles to Recover from Devastating Stock Decline
The premium hair care company Olaplex has experienced a dramatic fall from grace since making its public market debut in September 2021. What began as a promising entry into the stock market has transformed into one of the most significant value destructions in recent retail history.
The brand’s shares initially launched at $25 each, exceeding early forecasts and riding the wave of a robust IPO market that year. By early January 2022, the stock reached its peak at $29.41, representing the company’s zenith as a publicly traded entity.
However, the trajectory has been catastrophic since then. The stock has shed approximately 95% of its value, currently trading below $1.50 per share, while the broader S&P 500 index has climbed over 50% during the same timeframe. The company’s market capitalization now hovers around $1 billion.
Chief Executive Officer Amanda Baldwin expressed optimism about the company’s direction, stating that management feels encouraged by current momentum as they work to develop a business that matches their innovative scientific approach.
The company specializes in bond-building technology designed to strengthen and repair hair, distributing products through both direct-to-consumer channels and professional salon networks.
Legal Troubles and Consumer Backlash
The brand’s troubles began accumulating in 2022 with declining demand and regulatory hurdles. The situation deteriorated significantly in early 2023 when approximately 30 women filed a lawsuit alleging that Olaplex products caused hair loss and damage. The legal action specifically targeted an ingredient called lilial found in the formulations.
While Olaplex vigorously contested these allegations and removed the controversial ingredient from all products, the damage to consumer confidence proved lasting. Social media platforms became battlegrounds where customers criticized the brand’s formulations and reported adverse effects.
Although courts ultimately dismissed the lawsuit later in 2023, the reputational harm persisted. The stock lost more than half its value during that turbulent year and has never regained its footing.
Financial Performance Decline
The company’s financial results reflected this crisis. During fiscal 2023, domestic net sales plummeted 47.8% compared to the previous year, while net income crashed by 74.8%. These figures underscore the severity of the brand’s market position deterioration.
Meanwhile, competitive pressure intensified as emerging brands like K18, Ouai, and Redken capitalized on Olaplex’s struggles, capturing market share while the established company grappled with negative publicity.
New Leadership and Recovery Efforts
In late 2023, Olaplex brought aboard Baldwin, previously the head of beauty brand Supergoop, to spearhead a comprehensive turnaround strategy. Baldwin identified significant opportunities to rebuild customer relationships, develop innovative products, and refine the company’s public relations approach.
The new CEO positioned Olaplex as a pioneering force that combines beauty with scientific innovation, emphasizing the brand’s unique market position.
Recent product development includes a pre-shampoo treatment launched last month, representing the company’s latest advancement in bond-building technology and its commitment to innovation.
Mixed Financial Signals
Fourth-quarter earnings showed modest improvement, with net sales rising 4.3% to $105.1 million compared to the same period in 2024. However, full-year fiscal 2025 results revealed minimal growth of just 0.1%, causing shares to drop more than 20% following the announcement.
Industry Perspectives and Future Outlook
Celebrity hair stylist Tracey Cunningham, who has collaborated with the brand since 2013, remains a strong advocate. She recalls testing early products and immediately recognizing their transformative potential for hair coloring professionals. Cunningham continues using Olaplex treatments extensively in her Los Angeles salon, praising the technology’s evolution and effectiveness.
However, market analysts remain divided on the company’s prospects. JPMorgan Chase analysts maintain a pessimistic view, anticipating continued challenges over the coming quarters due to intensified competition, consumer financial stress, and difficult operating conditions.
Conversely, some industry observers see encouraging signs. Research conducted under Baldwin’s leadership revealed that while consumers previously viewed the brand as effective but cold and clinical, recent brand health tracking indicates improved perception as more approachable and appealing while maintaining its scientific credibility.
Analyst Optimism and Market Opportunities
Susan Anderson from Canaccord Genuity Global Capital Markets, who has followed Olaplex throughout most of its public existence, identifies positive developments including sales stabilization, product innovation, and distance from lawsuit-related fallout.
Anderson notes that negative factors are diminishing and believes consumers have largely moved past the hair loss allegations. She emphasizes that hair and scalp health remains a dynamic growth area within the beauty industry, presenting ongoing opportunities for product expansion.
Recent consumer surveys support this optimism, with Canaccord research showing Olaplex as the leading prestige hair brand among consumers aged 18 to 29.
Acquisition Interest and Future Prospects
Market speculation intensified in January when reports emerged of a potential takeover bid from German company Henkel, causing shares to surge over 30%. Industry observers view Olaplex as an attractive acquisition target given its current valuation and enduring brand loyalty despite recent challenges.
The combination of new leadership, product innovation, and potential strategic alternatives suggests multiple pathways for the company’s recovery, though success remains far from guaranteed in an increasingly competitive marketplace.